Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 11NIH 4NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Squamous Cell Carcinoma of Head and Neck 41Head and Neck Neoplasms 41Uterine Cervical Neoplasms 31Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 23Ovarian Neoplasms 16Urinary Bladder Neoplasms 14Stomach Neoplasms 12Carcinoma, Ovarian Epithelial 12Sarcoma 9Neuroblastoma 9Esophageal Neoplasms 9Fallopian Tube Neoplasms 8Medulloblastoma 7Endometrial Neoplasms 7Biliary Tract Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma Of Esophagus 7Teratoma 6Central Nervous System Neoplasms 6Brain Neoplasms 6Radiation Injuries 5Neoplasm Metastasis 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Esophageal Squamous Cell Carcinoma 5Brenner Tumor 5Anus Neoplasms 5Urethral Neoplasms 4Testicular Neoplasms 4

Interventions

Cisplatin 4Paclitaxel 3Docetaxel 3Taxes 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Gemcitabine 2Carboplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1mercaptoundecahydrododecaborate 1bicalutamide 1Vorinostat 1Triptorelin Pamoate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pilocarpine 1Methotrexate 1Irinotecan 1In Situ Hybridization 1Erlotinib Hydrochloride 1Doxorubicin 1Chemotherapy, Adjuvant 1CP protocol 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × Cisplatin × Clear all
NCT01220583 2026-05-27

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Radiation Therapy Oncology Group

Phase 2 Active not recruiting
252 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT01969578 2024-11-05

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
149 enrolled
Head & Neck

Adenocarcinoma, Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00079079 2023-08-04

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Canadian Cancer Trials Group

Phase 2 Completed
34 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00084435 2012-06-14

S0217

SWOG Cancer Research Network

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡